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Abstract
Background: Transforming growth factor α (TGFα) protects against gastric mucosal injury and
facilitates wound healing. However, its overexpression is known to induce hypertrophic
gastropathy resembling Menetrier's disease in transgenic (TG) mice on an FVB background, as one
of the authors reported previously. We studied another TGFα-expressing mouse line on a CD1
background, whose gastric mucosa appears normal. Since this TG mouse had a strong resistance
to ethanol-induced gastric injury, we considered the long-term effect of TGFα on several gastric
protection mechanisms.
Methods: TGFα-expressing transgenic (TG) mouse lines bearing human TGFα cDNA under the
control of the mouse metallothionein gene I promoter were generated on a CD1 mouse
background, and analyzed their ethanol injury-resistant phenotypes produced by TGFα.
Results: In the TG mucosa, blood flow was well maintained after ethanol injury. Further, neural
and inducible types of NO synthases were consistently and widely expressed in the TG mucosa,
compared with the limited distribution of neural type NO synthase in the luminal pit region of the
wild-type (WT) mucosa. COX-2 and its upstream transcription factor NfkB were constitutively
elevated in the TG mucosa even before ethanol administration, whereas they were induced in the
same region of the WT mucosa only after ethanol injury. Two anti-apoptotic proteins, HSP70 and
Bcl-2, were upregulated in the TG mucosa even before ethanol administration, while they were not
expressed in the WT mucosa before the injury. Furthermore, pro-caspase 3 activation was
inhibited in the TG mucosa, while it was converted to the active form in the WT mucosa following
ethanol administration.
Conclusion: We conclude that TGFα maintains the gastric mucosal defense against gastric injury
by integrating other cytoprotective mechanisms.
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Background
Ethanol has long been used to generate a hemorrhagic
gastric mucosal injury in rodents [1]. With oral adminis-
tration of absolute or hydrochloric acid-acidified ethanol,
extensive hemorrhagic lesions can be produced in the gas-
tric mucosa. This experimental gastric injury model has
been frequently used for gastric mucosal protection and
restitution studies. Indeed, a number of cytoprotective
compounds have been tested to evaluate their potency in
resisting gastric injury, including gastrointestinal hor-
mones, growth factors, prostaglandins, bioactive amines,
and mild irritants such as capsaicin [2-5]. Among these
compounds, epidermal growth factor (EGF) family
growth factors, notably transforming growth factor α
(TGFα), have been reported as potent cytoprotective com-
pounds against ethanol-, acetic acid-, or aspirin-induced
gastric injury [2,4].
TGFα was expressed in the rat gastric mucosa after oral
administration of acidified taurocholate or hydrochloric
acid, suggesting its reparative role in gastric injury [6].
TGFα given intraperitoneally protected against ethanol-
induced gastric injury with a significant increase in adher-
ent gastric mucin in rats [7]. The cytoprotective function
of TGFα appeared to be mediated by activation of phos-
pholipase C-γ1, but not by prostaglandins, and was inde-
pendent of the anti-secretory effect of TGFα [7]. On the
other hand, prostaglandins and their synthetic enzyme,
cyclooxygenase (COX), have long been proposed as cyto-
protective factors against gastric injury [5,8]. EGF has been
shown to express an inducible COX isoform, COX-2, in
the RGM1 rat gastric mucosal cell line through an ERK
MAP kinase pathway [9] and in Swiss 3T3 fibloblasts,
especially by co-stimulation with gastrin [10]. Further-
more, COX-2 expression by heparin-binding EGF-like
growth factor, a member of the EGF family growth factors,
was blocked by a specific EGF receptor (EGF-R) inhibitor
in the rat gastric mucosa [11]. Thus, the EGF-R signal
appears to mediate COX-2 induction in the gastric
mucosa.
The most important cytoprotective mechanisms include
gastric mucosal blood flow. EGF and TGFα have been
shown to exert cytoprotective effects via stimulation of
capsaicin-sensitive neurons with release of calcitonin
gene-related peptide (CGRP) and nitric oxide (NO) in rats
exposed to orogastric ethanol administration, resulting in
an increase in gastric mucosal blood flow [11,12]. In con-
trast, Konturek et al. minimized the role of the CGRP-
dependent increase in gastric blood flow by demonstrat-
ing that the administration of NO-releasing aspirin
offered protection against absolute ethanol-induced gas-
tric injury even in capsaicin-denervated rats, resulting in
the upregulation of heat shock protein 70 (HSP70)
expression and attenuation of the oxidative injury by
strong upregulation of antioxidative genes such as zinc
copper superoxide dismutase (SOD) and glutathione per-
oxidase [13].
TGFα was immunostained predominantly in GSM cells
along the gastric pit in humans [14], intensively in gastric
surface mucosal (GSM) cells over the proliferative zone
and weakly along the glandular region under the prolifer-
ative zone in rats [15], and markedly along the mucous
neck cell region in FVB/N strain mice [16]. On the other
hand, EGF-R was immunostained in GSM cells lining the
foveolar pit and mucous neck cell region to the lower
glandular region in humans [17]. In rats, EGF-R was local-
ized at the top-pit region and in the chief cell clusters at
the bottom of the gastric glands [15]. Although TGFα is
known to induce cell proliferation in primary-cultured rat
gastric mucosal cells [18], and hyperplastic proliferation
in the mucosa on the TGFα-expressing transgenic (TG)
mouse [19,20], the distribution of TGFα and EGF-R in ter-
minally differentiated gastric mucosal cells suggests that
TGFα exerts non-proliferative functions including anti-
apoptotic effects and gastric epithelial barrier formation
in an autocrine/paracrine manner. For example, TGFα
inhibited apoptosis of a mouse gastric mucosal cell line,
GSM06, by expressing anti-apoptotic Bcl-2 family pro-
teins through an NF-κB-dependent pathway [21]. Gastric
apical and basolateral EGF-R has been shown to induce a
decrease in paracellular permeability to acid for the pro-
tection of glandular cells in an acidic environment
[18,22]. Thus, TGFα exerts both proliferative and non-
proliferative effects on gastric mucosal functions, and
these diverse TGFα effects should be re-evaluated, at least
in terms of whether their results are derived from short-
term treatment using culture cell lines or from long-term
expression using TGFα-transgene-expressing animals.
A decade ago, one of the authors, H. Takagi, generated
TGFα-expressing TG mouse lines under the control of the
metallothionein gene promoter, and one of these lines
(MT100) exhibited hypertrophic gastropathy resembling
Menetrier's disease, as similarly shown by other investiga-
tors [19,20]. In contrast, another TG line (MT42) dis-
played a normal-appearing gastric mucosa, although
TGFα transgene was expressed to a similar extent in both
TG lines [20]. Since the MT42 line displayed a surprising
level of resistance to ethanol-induced injury to the gastric
mucosa, we considered that it could be useful for explor-
ing the non-proliferative effects of TGFα such as mucosal
resistance to ethanol injury. In the present study, we inves-
tigated the long-term effects of TGFα on ethanol-induced
gastric injury by analyzing changes in cytoprotective and
anti-apoptotic regulatory factors, including gastric blood
flow, NO synthase, COX-2, and apoptosis-associated pro-
teins such as HSP70, Bcl-2, and caspase 3.BMC Gastroenterology 2006, 6:22 http://www.biomedcentral.com/1471-230X/6/22
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Methods
TGFα-expressing transgenic mouse and ethanol-induced 
gastric injury
TGFα-expressing transgenic (TG) mouse lines bearing
human TGFα cDNA under the control of the mouse met-
allothionein gene I promoter were generated on a CD1 or
FVB mouse background, as described previously [20].
One of the TG lines, MT100 on an FVB mouse back-
ground, displayed hypertrophic gastropathy resembling
Menetrier's disease [20], whereas the other line, MT42 on
a CD1 mouse background, displayed a normal-appearing
gastric mucosa. The phenotype of the TGFα-TG mouse
appeared to depend on the mouse strain, because both the
MT100 and MT42 lines expressed a similar level of the
TGFα transgene in the stomach [20]. In the present study,
we used the MT42 line of TGFα-expressing TG male mice
and CD1 wild type (WT) male mice at ages 6 to 8 weeks.
The animals were maintained under controlled light (7:00
AM to 7:00 PM) with food and water provided ad libitum.
The mice, weighing 30–35 g, were fasted for 24 h before
the experiment but were allowed free access to water. All
experimental procedures affecting the mice were
approved by the Animal Care and Use Review Committee
at the Gunma University. The mice were then given oro-
gastric acidified ethanol (100 µl; 60% ethanol in 0.15
mol/L HCl). Three, six, and twelve hours after the acidi-
fied ethanol administration the mice were sacrificed for
the evaluation of gastric injury and immunohistochemi-
cal analyses, and for RNA and protein extraction for real
time PCR, Northern and Western blot analyses.
Physiological studies
Gastric acid secretion was measured as described previ-
ously [20,23]. Briefly, WT and TG mice were fasted for 3 h
and then anesthetized with ether. After the incision of
abdominal wall, the pyrolus was ligated, and the incision
was sutured. The gastric fluid was collected 4 h after the
pyrolus ligation. For maximal acid output, acid secretion
was stimulated by injecting pentagastrin subcutaneously
(500 µg/kg body weight). The gastric fluid was titrated
with 0.1 N NaOH to pH 7.0 using a microtitrator.
Gastric mucosal blood flow was measured with a laser
Doppler flowmeter (model SFA211, Advance Co., Tokyo)
by placing a probe on the surface of the gastric mucosa, as
described previously [24]. The flow signal was monitored
with the MacLab recording program. The blood flow was
expressed relative to the basal level.
Morphological studies
The thickness of the gastric mucosa was measured from
the highest part to the bottom of the gland with a microm-
eter. Similarly, the gastric injury lesions were measured
(width and longitude) with a micrometer to calculate the
injured area.
For immunostaining, we obtained antibodies as follows.
Polyclonal antibody to H+/K+-ATPase was obtained by
injecting rabbit parietal cell-microsomal fractions into
mice [25]. Rabbit polyclonal antibody to metallothionein
was a kind gift from Dr. Nagamine, Gunma University
School of Health Sciences [26]. We purchased antibodies
as follows: rabbit polyclonal antibody to TGFα, rabbit
polyclonal antibody to EGF-R, goat polyclonal antibody
to COX-2, rabbit polyclonal antibody to NFκB, and
mouse monoclonal antibody to nNOS and iNOS from
Santa Cruz Biotech. (Santa Cruz, CA); mouse monoclonal
antibody to proliferative-cell nuclear antigen (PCNA)
from Zymed Lab. (South San Francisco, CA); sheep anti-
body to human pepsinogen II from BioPur AB (Buben-
dorf, Switzerland), which also reacts to mouse
pepsinogen; rabbit polyclonal antibody to HSP70 from
Stressgen Biotech. (Victoria, BC, Canada); and mouse
monoclonal antibody to Bcl-2 from BD Biosciences (San
Diego, CA).
For horseradish peroxidase (HRP)-catalyzing immunohis-
tochemical staining, minced stomachs were fixed in neu-
tralized 10% formalin at 4°C for 24 h, and was then
embedded in paraffin for microtome sectioning. The
deparaffinized tissue sections were rehydrated and incu-
bated in 3% hydrogen peroxide solution to inhibit endog-
enous peroxidase activity. Then the sections were
incubated with a first antibody described above with an
appropriate dilution at room temperature for 30 min. A
secondary biotinylated antibody was selected based on
the first antibody-producing animal species, and was then
used with HRP-conjugated streptavidin. The HRP reaction
was performed with 3-amino-9-ethyl-carbazole and
hydrogen peroxide according to the instructions supplied
with the streptavidin-biotin staining Vectastatin Elite Kit
(Vectors Laboratories, Burlingame, CA). Positive stainings
appeared brown in color.
For immunofluorescent staining, minced stomachs were
fixed in 4% paraformaldehyde in 0.1 M phosphate buffer,
pH 7.4 at 4°C for 24 h. Small pieces of minced tissue
underwent saccharose replacement and were embedded
in OCT-compound in preparation for a frozen section
using a microtome. For the primary immunoreaction,
sliced sections were probed with a first antibody, and were
then incubated either with indodicarbocyanide (Cy3)-
conjugated affinity-purified donkey anti-rabbit, anti-
mouse IgG (Jackson ImmunoResearch, West Grove, PA),
or fluorescein isothiocyanate (FITC)-labeled anti-rabbit
IgG (Jackson ImmunoResearch), as a secondary antibody.
The secondary antibody IgG was selected based on the
species on which the first antibody was raised.BMC Gastroenterology 2006, 6:22 http://www.biomedcentral.com/1471-230X/6/22
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In situ detection of apoptotic cells was performed using
the In Situ Apoptosis Detection Kit (TAKARA BIO INC.
Tokyo, Japan). The kit contained a terminal deoxynucle-
otidyl transferase-mediated deoxyuridine triphosphate
biotin nick end-labelling (TUNEL) assay system. Stomach
sections were permeabilized with proteinase K, and the 3'-
OH ends of the DNA fragments were then stained follow-
ing the instructions supplied with the kit. The nuclei
stained dark brown were considered to be apoptotic cells.
RNA analysis
Stomachs were trimmed and the total RNAs were
extracted using TRIzol (Gibco BRL, Tokyo) according to
the protocol supplied by the manufacturer. For Northern
blot, the total RNA was electrophoresed on a 1.0% agarose
gel and was transferred to a nylon membrane (Amersham
Pharmacia Biotech, Tokyo). Hybridization was performed
with a probe of the human TGFα cDNA (917 bp) labeled
with [α-32P] deoxy-CTP. This probe recognizes human
TGFα mRNA, but does not mouse TGF mRNA.
Mouse TGFα mRNA level was measured using a real time
polymerase chain reaction (PCR) with glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) as an internal con-
trol. The real time PCR was carried out using the ABI Prism
7700 Sequence Detector and soft (Applied Biosystems,
Foster City, CA) using the DNA fluorescent dye SYBR
Green detection. Primers were designed using the Primer
Express design software (Applied Biosystems). The final
result for each sample was normalized by the respective
GAPDH value. Primer sequences are as follows: mouse
TGFα: 5'-CCTGAGCACCCGAAGAT-3' and 5'-CCTTC-
CCTCATGCCTTACT-3'; GAPDH: 5'-GTCGTGGATCT-
GACGTGCC-3' and 5'-TGCCTGCTTCACCACCTTCT-3'.
Western blot analysis
Gastric tissue samples were trimmed and total protein
from the gastric mucosa was homogenized in RIPA buffer
containing a cocktail of protease inhibitors (phenylmeth-
ylsulphonyl fluoride, pepstatin, leupeptin, and aprotinin)
(Roche Diagnostics, Mannheim, Germany). The superna-
tant was separated on an SDS-PAGE gel, and was then
blotted to a polyvinylidene difluoride membrane. The
membrane was probed with the following antibodies:
antibodies to iNOS, COX-1, COX-2, HSP70, and Bcl-2,
which were the same ones used for morphological studies;
mouse monoclonal antibody to Bax (Santa Cruz Bio-
tech.); rabbit polyclonal antibody to caspase 3 (Santa
Cruz Biotech.); and mouse monoclonal antibody to actin
filaments (Santa Cruz Biotech.). Antibody-reacted bands
were detected utilizing an ECL detection system (Amer-
sham, Buckinghamshire, UK).
Measurement of gastrin
Serum gastrin was measured using a gastrin radioimmu-
noassay kit (gastrin RIA kit, Dainabot, Tokyo, Japan). The
antibody is specific for gastrin with an amide moiety at its
carboxyl terminus.
Measurement of Prostaglandin E2
The gastric mucosa was homogenized at 4°C in lysis
buffer. Homogenates were centrifuged at 12000 rpm for
20 min, and the supernatants were subjected to prostag-
landin E2  assay using a Prostaglandin E2  Monoclonal
Enzyme Immunoassay Kit (Cayman Chemical, Ann
Arbor, MI), according to the manufacturer's instruction.
Statistical analysis
Statistical analysis was performed by repeated measure
analysis of variance (ANOVA) for the total length of the
gastric lesions by unpaired t-test for gastric mucosal blood
flow decrease ratio. All values are expressed as the mean ±
SE. P < 0.05 was accepted as statistically significant.
Results
Characterization of the TGFα-expressing TG mouse 
gastric mucosa
The WT CD1 strain and TGFα-transgene expressing MT42
line mice grew similarly and showed no noticeable differ-
ence in their features, behaviors, or lifespans. The greatest
thickness observed for the gastric wall and fundic glands
were 3.50 ± 0.18 mm and 2.33 ± 0.20 mm, respectively, in
the WT mice, and 3.85 ± 0.24 mm and 2.63 ± 0.16 mm,
respectively, in the TG mice; there were no significant dif-
ferences in the shape of the gastric mucosae and glands
between the WT and TG mice. In addition to the normal
appearance of the gastric mucosa, this TG mouse line also
had a normal-appearing liver, pancreas, and other organs.
We then compared acid secretion capacity between the
WT and TG mice. In the WT mice, maximal acid output
increased significantly from basal level of 25 ± 1.4 mEq/h
to 50 ± 5.8 mEq/h after the pentagastrin stimulation. By
contrast, in the TG mice, maximal acid output increased to
a less extent to 30 ± 5.7 mEq/h from the basal output of
23 ± 0.7 mEq/h (n = 5 in WT and TG mice). The blunted
acid output may reflect the reduced parietal cell mass in
the TG mucosa (Figure 1e).
Expression of TGFα transgene
TGFα-expressing cell-types were identified based on cell-
type-specific immunostaining and their mucosal location.
TGFα was reportedly immunostained along the GSM cells
in the gastric pit in humans [14] and rats [15], and along
the mucous neck cell region in the FVB strain mice [16].
In the present study, brown-colored TGFα-positive cells
were distributed along the foveolar region of both the WT
and TG mucosae, and along the lower glandular region ofBMC Gastroenterology 2006, 6:22 http://www.biomedcentral.com/1471-230X/6/22
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Characterization of the TGFα-expressing TG mucosa Figure 1
Characterization of the TGFα-expressing TG mucosa. Scale in each figure indicates 100 µm. (a) Distribution of TGFα-
expressing cells. Brown-colored TGFα-positive cells were visible along the luminal pit region in the WT mucosa, the elongated 
foveolar pit region, and the lower one-third of the glandular region in the TG mucosa. (b) Overlap of red-colored TGFα-posi-
tive cells and green-colored H+/K+-ATPase-positive parietal cells. Lower TGFα-positive cells in cluster are distinct from the 
green-colored parietal cells in the TG mucosa. (c) Northern blot of human TGFα mRNA and PCR-amplified mouse TGFα 
mRNA. Human TGFα mRNA is expressed in the TG mucosa alone (left panel), but PCR-amplified mouse TGFα mRNA is 
expressed similarly in both WT and TG mucosae (right panel). (d) Western blot of TGFα intermediate forms. TGFα precur-
sor (20 kDa) and its intermediate forms are visualized more intensively in the TG mucosa than in the WT mucosa. (e) Locali-
zation of EGF receptor in the gastric mucosa. EGF receptor (EGF-R) was stained with Cy3 (red) and H+/K+-ATPase was 
stained with FITC (green). EGF-R was immunostained moderately in the upper pit region and strongly in the lower glandular 
region similarly in both the WT and TG mucosae. (f) Distribution of metallothionein in the gastric mucosa. Metallothionein is 
immunostained strongly in the lower glandular region, and moderately along the foveolar region. (g) Elongation of the gastric 
pit of the TG mucosa. PCNA-positive cells are distributed at the upper-third region in the WT gastric glands, whereas they are 
distributed more numerously and broadly in the middle glandular region. (h) PAS staining shows elongated pit in the TG 
mucosa.BMC Gastroenterology 2006, 6:22 http://www.biomedcentral.com/1471-230X/6/22
Page 6 of 14
(page number not for citation purposes)
the TG mucosa (Figure 1a). The TGFα-positive cells along
the foveolar region appeared to be gastric pit cells, based
by their location (Figure 1b, upper panel), and those
along the lower glandular region of the TG mucosa did
not overlap with the green-colored H+/K+-ATPase-positive
parietal cells (Figure 1b, lower panel), but did overlap
with the pepsinogen-positive chief cells (data not shown).
The antibody we used for immunostaining for TGFα
could not distinguish between human and mouse TGFα,
but its mRNA probe could do so for the Northern blot
analysis. The human TGFα-transgene was expressed in the
TG mucosa while no expression was noted in the WT
mucosa (Figure 1c, left panel). In contrast, endogenous
mouse TGFα mRNA was similarly expressed in both the
WT and TG mucosae by real time PCR (Figure 1c, right
panel). TGFα is a 50 amino acid peptide, derived from its
160 amino acid membrane-spanning precursor cleaved
by tumor necrosis factor-α-converting enzyme (TACE)
[27,28]. With the surplus expression of the human TGFα-
transgene in the TG mucosa, an approximately 20 kDa
TGFα precursor and its intermediate forms were increased
by immunoblotting (Figure 1d).
Since both the precursor and processed forms were
equally active for stimulating EGF-R [28], we further
examined EGF-R localization in the mucosa. EGF-R was
localized heavily in the lower chief cell cluster region and
moderately in the mucous neck cell region and in the
foveolar pit region in both the WT and TG mucosae (Fig-
ure 1e), as was reported previously for the rat gastric
mucosa [15]. Since the TGFα transgene was controlled
under the mouse metallothionein gene [20] and metal-
lothionein has been reportedly produced in the gastric
mucosa [29], we examined the metallothionein-express-
ing cell-types in the mucosa. Immunohistochemically, we
noted metallothionein staining mostly along the lower
glandular region and scatteringly along the pit region of
the control CD1-strain gastric mucosa (Figure 1f). Thus,
the distribution of TGFα-expressing cell-types is similar to
that of metallothionein-expressing cells in the TG gastric
mucosa (Figures 1a and 1f).
In the WT mouse mucosa, the H+/K+-ATPase-positive pari-
etal cells were spread widely over the glandular region
except for the top-pit layer, whereas the H+/K+-ATPase-
positive glandular region was reduced in height in the TG
mucosa (Figure 1e). Indeed, the isthmus at the base of the
pit region, which was confirmed by PCNA staining, was
moved down to the middle of the TG mucosa (Figure 1g).
Moreover, PCNA-positive cells were thickly distributed in
the middle of the mucosa. Consistently, the PAS-staining-
positive foveolar pit was elongated in the TG mucosa in
contrast to the short pit in the WT mucosa (Figure 1h).
Thus, although the height of the gastric mucosa was simi-
lar between the WT and TG mucosae, the proliferative
zone was moved down and the foveolar pit region was
more elongated with a reduced glandular region in the TG
mocosa. Since the growth of pit cells is strongly enhanced
by gastrin [25,30], we compared the serum gastrin levels
between the WT and TG mice but found no increase in the
levels of serum gastrin in the TG mouse (WT, 213 ± 41 pg/
ml; TG, 263 ± 47 pg/ml, n = 5, p = 0.438).
Ethanol-induced gastric injury in the WT and TG mouse 
mucosae
Orogastric administration of acidified ethanol (100 µl)
caused hemorrhagic injury in the TG mucosa (Figure 2a,
left). Histologically the injury peeled off the pit and isth-
mus regions and reached to the mid-glandular region
(Figure 2b, left). In contrast, this sort of injury in the TG
mouse mucosa was not notable (Figure 2a, right). The
injury was histologically limited to the luminal pit region
(Figure 2b, right). In the WT mucosa, the injured area
increased rapidly with a peak at 6 h after the ethanol
administration, whereas in the TG mucosa the area
increased slowly and minimally without a marked peak
(Figure 2c). Consistently, apoptotic cells shown by the
TUNEL staining distributed deeply to the lower glandular
region 3 h after the ethanol administration in the WT
mucosa, whereas the apoptotic cells were confined to the
pit region but did not extend to the glandular region in the
TG mucosa (Figure 2d).
Gastric mucosal blood flow in the ethanol-treated mucosa
Although a number of cytoprotective regulatory factors
have been reported, including NO, CGRP, COX2, and
HSP70 [12,13,31,32], mucosal blood flow has been pro-
posed as a primary factor for the protection and restitu-
tion of ethanol-induced gastric injury [1,33]. We
measured gastric blood flow by placing a probe of the
laser Doppler flowmeter on the gastric mucosa accessed
via an exposed abdominal wall in the anesthetized
mouse. Gastric blood flow decreased marked by 43.5 ±
6.37% after the ethanol administration on the gastric
mucosa of the WT mouse (Figure 3). In contrast, it only
decreased by 17.2 ± 9.21% after the ethanol administra-
tion on the TG mucosa (Figure 3). Thus, the gastric blood
flow was well maintained in the TG mucosa even after eth-
anol treatment. Since mucosal ischemia is one of the most
important ulcerogenic factors [33], the maintenance of
gastric blood flow does appear to be an essential factor for
mucosal protection.
Expression of cytoprotective proteins: NO synthase, COX-
2, and HSP70
To explore the mechanism of high blood flow mainte-
nance in the TG mucosa, we examined the expression of
NO synthases, which makes NO from arginine, and
relaxes vascular smooth muscles via cGMP-dependent
protein kinase [34]. There are three types of NO synthaseBMC Gastroenterology 2006, 6:22 http://www.biomedcentral.com/1471-230X/6/22
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Ethanol-induced gastric injury in the gastric mucosae Figure 2
Ethanol-induced gastric injury in the gastric mucosae. (a) Macroscopic view of the gastric mucosa. Scale: 5 mm. Both 
mucosae are 6 h after ethanol administration. Note that the WT mucosa displays extensive hemorrhagic lesions, in contrast, 
the TG mucosa looks undamaged after ethanol administration. (b) Hematoxylin and eosin staining of ethanol-injured WT 
mucosa (left) and TG mucosa (right). Note the deep ulcer formation in the WT mucosa. Scale: 100 µm. (c) Time course of eth-
anol-induced gastric injury. Injured area is plotted against time up to 12 h after the ethanol administration. Each point repre-
sents an average of five mice. p < 0.05 (d) TUNEL staining of WT mucosa (left) and TG mucosa (right). Both sections are 
consecutive to those in 2B, respectively. Apoptotic cells are visible with dark-brown nuclei. Numerous apoptotic cells are 
noted in the WT mucosa. All photos were 6 h after the ethanol administration. Scale: 100 µm.
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(NOS): neural NOS (nNOS), inducible NOS (iNOS), and
endothelial NOS (eNOS). nNOS and eNOS are constitu-
tively expressed, whereas iNOS is induced upon gastric
injury [35]. nNOS was distributed similarly to the PAS-
staining over the foveolar pit region (Figure 1g); it was
observed over the elongated pit of the TG mucosa and was
limited to the luminal pit of the WT mucosa (Figure 4a).
eNOS was weakly scattered over the entire gastric mucosa
similarly in both the WT and TG mucosae (data not
shown). The iNOS staining was negligible in the WT
mucosa, although it was highly induced in the lower glan-
dular region after the mucosa was exposed to ethanol (Fig-
ure 4b). In the TG mucosa, iNOS was constitutively
expressed in the lower glandular region similarly before
and after the injury (Figure 4b), which appears to further
contribute to the maintenance of high blood flow.
Prostaglandins were proposed as a major cytoprotective
factor over three decades ago [8] and their roles have been
extensively studied [36,37]. The role of the prostaglandin-
forming enzymes, COX-1 and COX-2, has been controver-
sial in the mucosal protection against gastric irritants
[7,11,32]. We examined the expression of COX in the WT
and TG mucosae during ethanol injury. The expression of
COX-1 did not differ between the WT and TG mucosae,
nor before or after the ethanol injury (Figure 5b). COX-2
was not detectable in the WT mucosa, but its expression
became evident 6 h after ethanol injury, and its staining
was localized to the lower glandular region (Figure 5a and
5b). In the TG mucosa, the COX-2 immunostaining was
intense at the same region even before the injury and
remained positive after the injury (Figure 5a). Since COXs
have been shown to be expressed in mesenchymal cells
such as fibroblasts and mononuclear cells in the gastric
mucosa [38], and the streptoavidin/biotin/HPR method
sometimes presents false-positive staining, we performed
immunofluorescent staining using a frozen section which
confirmed COX expression similarly in the lower glandu-
Immunostaining of NO synthases in the gastric mucosa Figure 4
Immunostaining of NO synthases in the gastric 
mucosa. Scale: 100 µm. (a) nNOS immunostaining. nNOS 
was visible along the pit region, resulting in its wider distribu-
tion along the elongated pit in the TG mucosa. (b) iNOS 
immunostaining. iNOS was induced in the lower glandular 
region after ethanol injury in the WT mucosa, whereas it was 
constitutively expressed in the same region of the TG 
mucosa irrespective of ethanol injury.
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Assessment of gastric mucosal blood flow in the gastric  mucosae Figure 3
Assessment of gastric mucosal blood flow in the gas-
tric mucosae. Gastric mucosal blood flow was assessed by 
comparing the blood flow ratio before and after the ethanol 
treatment. The ratio was obtained as a percent against the 
blood flow before the treatment, which was much larger in 
the WT mucosa than in the TG mucosa. *p < 0.03.
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COX-2 and NFκB expression in the gastric mucosa Figure 5
COX-2 and NFκB expression in the gastric mucosa. (a) Immunostaining of COX-2. COX-2 was intensively induced 
after the injury at the lower glandular region of the WT mucosa, whereas it was constitutively expressed in the same region of 
the TG mucosa even before the injury. Ethanol-injured mucosa was stained 6 h after the ethanol administration. Scale: 100 µm. 
(b) Immunoblotting of COX-2 and COX-1. The blots were measured 0, 3, and 6 h after the injury. Actin filaments were used 
as a control. Note that COX-2 was intensively expressed before the injury in the TG mucosa. (c) Measurement of prostaglan-
din E2. Prostaglandin E2 levels were measured before the ethanol treatment in the WT and TG mucosae. n = 5, p = 0.013. (d) 
Immunostaining of NFκB. NFκB was intensively induced after the injury at the same lower glandular region of the WT mucosa 
as was COX-2. In contrast, NFκB was constitutively expressed in the same region of the TG mucosa even before the injury. 
Scale: 100 µm.
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lar region of the TG mucosa (data not shown). By immu-
noblotting, COX-2 increased after the injury in the WT
mucosa, whereas it was highly elevated to a similar extent
before and after the injury (Figure 5b). Consistently, pros-
taglandin E2 levels were significantly higher in the TG
mucosa than in the WT mucosa (Figure 5c). Furthermore,
NFκB, a transcription factor responsible for COX-2 gene
expression, was localized to the lower glandular region of
the TG mucosa even before the ethanol treatment (Figure
5d), suggesting that TGFα transgene causes the constitu-
tive expression of NFκB [21].
Gastric irritants are known to induce heat shock protein
70 (HSP70), which chaperones denatured proteins for
renaturation or clearance [39]. HSP70 was not detected in
the WT mucosa, but after ethanol injury it was observed
extensively over the glandular region, and scatteringly in
the pit region of the WT mucosa (Figure 6a). In contrast,
it was visible at the lower glandular region of the TG
mucosa similarly before and after ethanol treatment (Fig-
ure 6a). By immunoblotting, HSP70 was not detected
before ethanol injury but appeared 3 h to 12 h after the
injury in the WT mucosa (Figure 6b). In contrast, it was
already elevated before the injury and increased moder-
ately after the injury (Figure 6b).
Collectively, the three cytoprotection-associated proteins,
iNOS, COX-2, and HSP70, were negligible in expression
before the injury and highly induced after the injury in the
WT mucosa, but they stayed elevated similarly before and
after the injury in the TG mucosa.
Expression of apoptosis-associated proteins in the gastric 
mucosa
As shown with the TUNEL staining in Figure 2d, the
TGFα-expressing mucosa was strongly resistant to ethanol
injury. Initially, we examined the expression of anti-apop-
totic Bcl-2 and pro-apoptotic Bax by immunoblotting.
Bcl-2 and Bax were slightly expressed in the WT mucosa
before the injury; after the injury, Bax increased inten-
sively whereas Bcl-2 increased to a lesser extent (Figure
7a). In the TG mucosa, Bcl-2 was expressed even before
the injury and remained elevated after the injury, whereas
Bax decreased to a negligible level after the injury. By
immunostaining, Bcl-2 was positive in the lower glandu-
lar region of the TG mucosa before the injury, but no
staining was visible in the WT mucosa. After the ethanol
injury, Bcl-2 appeared strongly along the periphery of the
injured lesion in the WT mucosa, in contrast, it stained
similarly to the pretreatment level in the TG mucosa (Fig-
ure 7b). Thus, the constitutive expression of Bcl-2 may
contribute to the anti-apoptotic feature of the TG mucosa
against ethanol injury. Evidence of the active form of cas-
pase-3, an executive caspase, was consistently absent in
the TG mucosal cell extract before and after the injury,
whereas it was intensively detected in the WT mucosa after
the injury, although the proform remained similarly
before and after the injury in both the WT and TG
mucosae (Figure 7c).
Discussion
EGF family growth factors including TGFa have been pro-
posed as integrative cytoprotective factors against gastric
injury [2,4]. The effects of TGFa have been tested by
administrating it to animals or culture cells for a short
term, and thus the reported cytoprotective mechanisms of
TGFa have been somewhat variable [7,12,24,31,40-42].
TGFa is known to be a potent growth-promoting factor
leading to hypertrophic growth in the gastric mucosae
[19,20]. In contrast, the EGF-R signal is known to activate
non-proliferative functions such as the induction of
HSP70 expression in the gastric mucosa Figure 6
HSP70 expression in the gastric mucosa. (a) Immunos-
taining of HSP70. HSP70 was induced along the necrotic 
region and the lower glandular region of the WT mucosa 
after ethanol injury, whereas it was constitutively expressed 
in the lower glandular region of the TG mucosa before and 
after the injury. Ethanol-injured mucosa was stained 6 h after 
the ethanol administration. Scale: 100 µm. (b) Immunoblot-
ting of HSP70. HSP70 blot was assessed 0, 3, 6, 12 h after the 
ethanol injury. HSP was induced after ethanol injury in the 
WT mucosa, while it was constitutively expressed in the TG 
mucosa before and after the injury.
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Expression of apoptosis-associated proteins Figure 7
Expression of apoptosis-associated proteins. (a) Immunoblot of Bax and Bcl-2. Bax was strongly induced at the 3 h and 6 
h time points in the WT mucosa, whereas it was reduced to a negligible level in the TG mucosa after ethanol injury. Bcl-2 was 
stably expressed similarly before and after the injury in the TG mucosa, whereas it was increased to some extent at 6 h after 
the injury in the WT mucosa. (b) Immunostaining of Bcl-2. Bcl-2 was not visible in the TG mucosa before the injury, but 
appeared along the border region of necrotic area after the injury. In contrast, Bcl-2 was constitutively induced over the TG 
mucosa even before the injury, and the staining was confined to the lower glandular region after the injury. Scale: 100 µm. (c) 
Immunoblot of caspase 3. After the injury, a 17 kDa active form of caspase 3 appeared in the WT mucosa, whereas it did not 
in the TG mucosa. A 32 kDa proform was unchanged both in the WT and TG mucosae.
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potent cytoprotective trefoil peptides, which are produced
from the gastrointestinal mucosa, through an EGF-R/MAP
kinase pathway [43]. Therefore, although high levels of
TGFa can cause hypertrophic gastropathy, appropriate lev-
els appear to maintain mucosal resistance to gastric injury.
However, since the broad presence of PCNA-positive cells
shown in Figure 1g indicates the proliferative action of
TGFa to gastric precursor cells in the TG mucosa, it does
not seem appropriate to categorize the action of TGFa as
either proliferative or non-proliferative for gastric protec-
tion. More appropriate is to evaluate the diverse effects of
TGFa using a long-term TGFa-expressing model. Using
such a TGFa-transgene-expressing TG mouse model
whose gastric mucosa showed a strong resistance to etha-
nol injury (Figure 2), we found that the integrative mech-
anisms of TGFa involve at least three categories of
cytoprotective regulators: NO synthases in relation with
gastric blood flow, COX-2, and apoptosis-associated regu-
lators such as Bcl-2 and Bax.
Gastric blood flow is known to contribute substantially to
mucosal protection against gastric injury [33]. In the
present study, a laser Doppler flowmeter analysis revealed
a significant maintenance of blood flow when acidified
ethanol was applied onto the mucosal surface of the TG
mouse (Figure 3). Since vascular dilation occurs even in
the high dose capsaicin-denervated gastric mucosa where
increased levels of NO contribute greatly [13], we con-
firmed the expression of NOS in the mucosa. nNOS was
expressed at the luminal pit region as previously reported
[35]. Since the pit region is elongated to half of the gastric
gland in length in the TG mucosa, the nNOS-expressing
region was much wider than that in the WT mucosa. Fur-
thermore, iNOS was constitutively expressed along the
lower glandular region in the TG mucosa, in contrast to
the negligible expression of iNOS unless ethanol was
applied to the WT mucosa (Figure 4). nNOS has been
reported to be induced by EGF in guinea pig gastric
mucosal primary-cultured cells [44], and in human
HaCaT keratinocytes [45]. In contrast, iNOS, a key regula-
tor of oxidant-induced epithelial barrier disruption, has
been reportedly downregulated through an EGF-R down-
stream ζ-isoform of protein kinase C for gastric protection
using colorectal carcinoma-derived Caco-2 cells [46]. We
postulate that the long-term effect of TGFα on iNOS
induction may be different from its short-term effect seen
in culture cells.
Previously, prostaglandins have been shown to increase in
parallel with the expression of COX-2 protein after ulcer
formation in rats [32]. However, intraperitoneal adminis-
tration of TGFα did not induce prostaglandin E2 release
into the gastric juice nor did it increase gastric tissue levels
of prostaglandin E2 [7]. The protective effect of TGFα to
ethanol-induced mucosal injury was not interrupted by
indomethacin-induced depletion of prostaglandin E2 in
the rat gastric mucosa [42]. Although the roles of prostag-
landins in gastric protection are controvertial, we found
that COX-2 and its upstream transcription factor NFκB are
markedly expressed in the TGFα-expressing TG mucosa
(Figure 5a and 5d). Our findings suggest that COX-2 is
induced by NFκB under the control of TGFα in gastric
mucosal cells. Consistently, prostaglandin E2 levels were
muchi more elevated in the TG mucosa than in the WT
mucosa (Figure 5c).
In response to environmental or physiological stress, such
as exposure to heat, ethanol, heavy metals, and water-
immersion stress, heat shock proteins such as HSP70 are
induced in the gastric mucosa [39,47]. HSPs are known to
play a role in refolding of denatured proteins and facilitate
the recovery of damaged cellular functions. HSP70 is also
thought to interrupt stress-induced apoptosis pathways at
several steps, including a cytochrome C releasing step
from mitochondria, and a pro-caspase activation step by
directly interacting with Apaf-1 [48]. In the present study,
HSP70 was already elevated in the TG mucosa before eth-
anol injury, in contrast to the almost completely lack of
HSP70 expression without injury in the WT mucosa (Fig-
ure 6). Together with HSP70, anti-apoptotic Bcl-2
remained similarly elevated before and after the ethanol
injury, but pro-apoptotic Bax was down-regulated in the
TG mucosa after the injury (Figure 7). Bcl-2 is an anti-
apoptotic protein which resides on the mitochondrial
outer membrane and inhibits channel formation of Bax, a
pro-apoptotic protein of the same Bcl-2 family, through
which cytochrome C leaks to the cytoplasm [49,50]. Thus,
constitutive expression of Bcl-2 by TGFα may overcome
unfavorable ethanol-exposure stress at least by suppress-
ing Bax activation. Once the Bcl-2 function is suppressed,
cytochrome C and other apoptogenic factors are released
through the Bax channel, and cytochrome C associates
with Apaf-1 to promote the activation of the initiator cas-
pase, pro-caspase 9, whose active form subsequently acti-
vates the effecter caspase, pro-caspase 3. Caspase 3 cleaves
the inhibitor of caspase-activated DNase (ICAD) to
release CAD, which then causes DNA fragmentation
[50,51]. In the present study, active 17 kDa caspase 3 was
not formed in the TG mucosa, whereas it was markedly
formed in the WT mucosa after the injury. Thus, we pro-
pose that the inhibitory effect of Bcl-2 on the release of
cytochrome C, and the HSP70 block of cytochrome C-ini-
tiated apoptosome formation to produce activated cas-
pase 9, resulted in the suppression of caspase 3 formation
from its precursor [50,52].
The strong resistance of TGFα-expressing gastric mucosa
to ethanol injury appears to involve at least three cytopro-
tective mechanisms: a well-maintained gastric blood flow
partly due to NO synthase expression by TGFα; constitu-BMC Gastroenterology 2006, 6:22 http://www.biomedcentral.com/1471-230X/6/22
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tive expression of COX-2, which produces prostaglandins
that may recruit GSM precursor cells to the injured pit
region [53]; and upregulation of anti-apoptotic proteins
such as HSP70 and Bcl-2, downregulation of pro-apop-
totic Bax, and inhibition of pro-caspase 3 activation.
These distinct cytoprotection mechanisms appear to con-
nect in an integrated manner.
Conclusion
We propose that non-pathological levels of long-term
TGFα expression may enhance the protective capacity of
the gastric mucosa against injury and may help maintain
the integration of mucosal functions by activating other
essential cytoprotective factors such as mucosal blood
flow, COX-2, and anti-apoptotic regulators such as HSP70
and Bcl-2 through these interconnecting pathways.
Abbreviations
TGFα, transforming growth factor α; TG, transgenic; WT,
wild-type; EGF-R, epidermal growth factor receptor; COX,
cyclooxygenase: NOS, nitric oxide synthase; HSP, heat
shock protein; GSM, gastric surface mucosa; HRP, horse-
radish peroxydase
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
TK performed immunohistochemistry, Western blotting,
Northern blotting, maintained transgenic mice, and per-
formed genotype analysis with some help from SK, NS,
NH and KS. MY performed gastric blood flow measure-
ments. HT, TT and MM supervised the first author TK. All
authors read and approved the final manuscript.
Acknowledgements
We thank Ms. M. Kosaki for secretarial assistance. This work was sup-
ported by a grant of the 21st Century Center of Exellence Program, and 
that from the Ministry of Education, Culture, Sports, Science and Technol-
ogy of Japan.
References
1. Gonul B, Akbulut KG, Ozer C, Yetkin G, Celebi N: The role of
transforming growth factor alpha formulation on aspirin-
induced ulcer healing and oxidant stress in the gastric
mucosa.  Surg Today 2004, 34:1035-1040.
2. Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ: Epi-
dermal growth factor-related peptides and their relevance
to gastrointestinal pathophysiology.  Gastroenterology 1995,
108:564-580.
3. Kamimura H, Konda Y, Yokota H, Takenoshita S, Nagamachi Y,
Kuwano H, Takeuchi T: Kex2 family endoprotease furin is
expressed specifically in pit-region parietal cells of the rat
gastric mucosa.  Am J Physiol 1999, 277:G183-G190.
4. Nakajima T, Konda Y, Izumi Y, Kanai M, Hayashi N, Chiba T, Takeuchi
T: Gastrin stimulates the growth of gastric pit cell precursors
by inducing its own receptors.  Am J Physiol Gastrointest Liver Physiol
2002, 282:G359-G366.
5. Potter CL, Hanson PJ: Exogenous nitric oxide inhibits apoptosis
in guinea pig gastric mucous cells.  Gut 2000, 46:156-162.
6. Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by
prostaglandins in rats. Prevention of gastric necrosis pro-
duced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal
injury.  Gastroenterology 1979, 77:433-43.
7. Slice LW, Hodikian R, Zhukova E: Gastrin and EGF synergisti-
cally induce cyclooxygenase-2 expression in Swiss 3T3
fibroblasts that express the CCK2 receptor.  J Cell Physiol 2003,
196:454-463.
8. Romano M, Polk WH, Awad JA, Arteaga CL, Nanney LB, Wargovich
MJ, Kraus ER, Boland CR, Coffey RJ: Transforming growth factor
alpha protection against drug-induced injury to the rat gas-
tric mucosa in vivo.  J Clin Invest 1992, 90:2409-2421.
9. Sugiyama N, Tabuchi Y, Horiuchi T, Obinata M, Furusawa M: Estab-
lishment of gastric surface mucous cell lines from transgenic
mice harboring temperature-sensitive simian virus 40 large
T-antigen gene.  Exp Cell Res 1993, 209:382-387.
10. Sunnarborg SW, Hinkle CL, Stevenson M, Russell WE, Raska CS,
Peschon JJ, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, Lee DC:
Tumor necrosis factor-alpha converting enzyme (TACE)
regulates epidermal growth factor receptor ligand availabil-
ity.  J Biol Chem 2002, 277:12838-12845.
11. Konda Y, Yokota H, Kayo T, Horiuchi T, Sugiyama N, Tanaka S,
Takata K, Takeuchi T: Proprotein-processing endoprotease
furin controls the growth and differentiation of gastric sur-
face mucous cells.  J Clin Invest 1997, 99:1842-1851.
12. Karam S, Leblond CP: Origin and migratory pathways of the
eleven epithelial cell types present in the body of the mouse
stomach.  Microsc Res Tech 1995, 31:193-214.
13. Massague J: Transforming growth factor-alpha. A model for
membrane-anchored growth factors.  J Biol Chem 1990,
265:21393-21396.
14. Orsini B, Calabro A, Milani S, Grappone C, Herbst H, Surrenti C:
Localization of epidermal growth factor/transforming
growth factor-alpha receptor in the human gastric mucosa.
An immunohistochemical and in situ hybridization study.  Vir-
chows Arch A Pathol Anat Histopathol 1993, 423:57-63.
15. Kang JY, Teng CH, Chen FC, Wee A: Role of capsaicin sensitive
nerves in epidermal growth factor effects on gastric mucosal
injury and blood flow.  Gut 1998, 42:344-350.
16. Takano H, Satoh M, Shimada A, Sagai M, Yoshikawa T, Tohyama C:
Cytoprotection by metallothionein against gastroduodenal
mucosal injury caused by ethanol in mice.  Lab Invest 2000,
80:371-377.
17. Peskar BM: Neural aspects of prostaglandin involvement in
gastric mucosal defense.  J Physiol Pharmacol 2001, 52:555-568.
18. Chen MC, Lee AT, Soll AH: Mitogenic response of canine fundic
epithelial cells in short-term culture to transforming growth
factor alpha and insulinlike growth factor I.  J Clin Invest 1991,
87:1716-1723.
19. Dempsey PJ, Goldenring JR, Soroka CJ, Modlin IM, McClure RW, Lind
CD, Ahlquist DA, Pittelkow MR, Lee DC, Sandgren EP: Possible role
of transforming growth factor alpha in the pathogenesis of
Menetrier's disease: supportive evidence form humans and
transgenic mice.  Gastroenterology 1992, 103:1950-1963.
20. Takahashi S, Shigeta J, Inoue H, Tanabe T, Okabe S: Localization of
cyclooxygenase-2 and regulation of its mRNA expression in
gastric ulcers in rats.  Am J Physiol Gastrointest Liver Physiol 1998,
275:G1137-G1145.
21. Karam SM, Leblond CP: Dynamics of epithelial cells in the cor-
pus of the mouse stomach. I. Identification of proliferative
cell types and pinpointing of the stem cell.  Anat Rec 1993,
236:259-279.
22. Chen MC, Solomon TE, Kui R, Soll AH: Apical EGF receptors reg-
ulate epithelial barrier to gastric acid: endogenous TGF-
alpha is an essential facilitator.  Am J Physiol Gastrointest Liver Phys-
iol 2002, 283:G1098-G1106.
23. Li Z, Jansen M, Ogburn K, Salvatierra L, Hunter L, Mathew S, Figueir-
edo-Pereira ME: Neurotoxic prostaglandin J2 enhances
cyclooxygenase-2 expression in neuronal cells through the
p38MAPK pathway: a death wish?  J Neurosci Res 2004,
78:824-836.
24. Zhang B, Hosaka M, Sawada Y, Torii S, Mizutani S, Ogata M, Izumi T,
Takeuchi T: Parathyroid hormone-related  protein induces
insulin expression through activation of MAP kinase-specific
phosphatase-1 that dephosphorylates c-Jun NH2-terminal
kinase in pancreatic beta-cells.  Diabetes 2003, 52:2720-2730.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Gastroenterology 2006, 6:22 http://www.biomedcentral.com/1471-230X/6/22
Page 14 of 14
(page number not for citation purposes)
25. Konturek PC, Brzozowski T, Kania J, Konturek SJ, Hahn EG: Nitric
oxide-releasing aspirin protects gastric mucosa against eth-
anol damage in rats with functional ablation of sensory
nerves.  Inflamm Res 2003, 52:359-365.
26. Takagi H, Jhappan C, Sharp R, Merlino G: Hypertrophic gastropa-
thy resembling Menetrier's disease in transgenic mice over-
expressing transforming growth factor alpha in the stomach.
J Clin Invest 1992, 90:1161-1167.
27. Milani S, Calabro A: Role of growth factors and their receptors
in gastric ulcer healing.  Microsc Res Tech 2001, 53:360-371.
28. Takagi H, Fukusato T, Kawaharada U, Kuboyama S, Merlino G, Tsut-
sumi Y: Histochemical analysis of hyperplastic stomach of
TGF-alpha transgenic mice.  Dig Dis Sci 1997, 42:91-98.
29. Taupin D, Wu DC, Jeon WK, Devaney K, Wang TC, Podolsky DK:
The trefoil gene family are coordinately expressed immedi-
ate-early genes: EGF receptor- and MAP kinase-dependent
interregulation.  J Clin Invest 1999, 103:R31-R38.
30. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E,
Trzaskos JM, Evans JF, Taketo MM: Suppression of intestinal poly-
posis in Apc delta716 knockout mice by inhibition of cycloox-
ygenase 2 (COX-2).  Cell 1996, 87:803-809.
31. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H,
Akamatsu T, Kasuga M: Induction of cyclooxygenase 2 in gastric
mucosal lesions and its inhibition by the specific antagonist
delays healing in mice.  Gastroenterology 1997, 112:387-397.
32. Nasim MM, Thomas DM, Alison MR, Filipe MI: Transforming
growth factor alpha expression in normal gastric mucosa,
intestinal metaplasia, dysplasia and gastric carcinoma – an
immunohistochemical study.  Histopathology 1992, 20:339-343.
33. Vongthavaravat V, Mesiya S, Saymeh L, Xia Y, Harty RF: Mechanisms
of transforming growth factor-alpha (TGF-alpha) induced
gastroprotection against ethanol in the rat: roles of sensory
neurons, sensory neuropeptides, and prostaglandins.  Dig Dis
Sci 2003, 48:329-333.
34. Rokutan K, Teshima S, Kawai T, Kawahara T, Kusumoro K,
Mizushima T, Kishi K: Geranylgeranylacetone stimulates mucin
synthesis in cultured guinea pig gastric pit cells by inducing a
neuronal nitric oxide synthase.  J Gastroenterol 2000, 35:673-681.
35. Hirose M, Miwa H, Kobayashi O, Oshida K, Misawa H, Kurosawa A,
Watanabe S, Sato N: Inhibition of proliferation of gastric epi-
thelial cells by a cyclooxygenase 2 inhibitor, JTE522, is also
mediated by a PGE2-independent pathway.  Aliment Pharmacol
Ther 16 Suppl 2002, 2:83-89.
36. Helmer KS, West SD, Shipley GL, Chang L, Cui Y, Mailman D, Mercer
DW: Gastric nitric oxide synthase expression during endo-
toxemia: implications in mucosal defense in rats.  Gastroenter-
ology 2002, 123:173-186.
37. Yanaka A, Suzuki H, Shibahara T, Matsui H, Nakahara A, Tanaka N:
EGF promotes gastric mucosal restitution by activating
Na(+)/H(+) exchange of epithelial cells.  Am J Physiol Gastrointest
Liver Physiol 2002, 282:G866-G876.
38. Polk WH Jr, Dempsey PJ, Russell WE, Brown PI, Beauchamp RD, Bar-
nard JA, Coffey RJ Jr: Increased production of transforming
growth factor alpha following acute gastric injury.  Gastroenter-
ology 1992, 102:1467-1474.
39. Wallace JL: Nonsteroidal anti-inflammatory drugs and the
gastrointestinal tract. Mechanisms of protection and heal-
ing: current knowledge and future research.  Am J Med 2001,
110:19S-23S.
40. Halter F, Tarnawski AS, Schmassmann A, Peskar BM: Cyclooxygen-
ase 2-implications on maintenance of gastric mucosal integ-
rity and ulcer healing: controversial issues and perspectives.
Gut 2001, 49:443-453.
41. Kanai M, Konda Y, Nakajima T, Izumi Y, Takeuchi T, Chiba T: TGF-
alpha inhibits apoptosis of murine gastric pit cells through an
NF-kappaB-dependent pathway.  Gastroenterology 2001,
121:56-67.
42. Watanabe D, Otaka M, Mikami K-I, Yoneyama K, Goto T, Miura K,
Ohshima S, Lin J-G, Shibuya T, Segawa D, Kataoka E, Konishi N,
Odashima M, Sugawara M, Watanabe S: Expression of a 72-kDa
heat shock protein, and its cytoprotective function, in gastric
mucosa in cirrhotic rats.  J Gastroenterol 2004, 39:724-733.
43. Tsukimi Y, Okabe S: Recent advances in gastrointestinal patho-
physiology: role of heat shock proteins in mucosal defense
and ulcer healing.  Biol Pharm Bull 2001, 24:1-9.
44. Sasaki E, Tominaga K, Watanabe T, Fujiwara Y, Oshitani N, Mat-
sumoto T, Higuchi K, Tarnawski AS, Arakawa T: COX-2 is essential
for EGF induction of cell proliferation in gastric RGM1 cells.
Dig Dis Sci 2003, 48:2257-2262.
45. Boissel J-P, Ohly D, Bros M, Godtel-Armbrust U, Forstermann U,
Frank S: The neuronal nitric oxide synthase is upregulated in
mouse skin repair and in response to epidermal growth fac-
tor in human HaCaT keratinocytes.  J INVEST DERMATOL 2004,
123:132-139.
46. Banan A, Zhang L, Fields JZ, Farhadi A, Talmage DA, Keshavarzian A:
PKC-zeta prevents oxidant-induced iNOS upregulation and
protects the microtubules and gut barrier integrity.  Am J
Physiol Gastrointest Liver Physiol 2002, 283:G909-G922.
47. Yang C-M, Chien C-S, Hsiao L-D, Luo S-F, Wang C-C: Interleukin-
1beta-induced cyclooxygenase-2 expression is mediated
through activation of p42/44 and p38 MAPKS, and NF-kap-
paB pathways in canine tracheal smooth muscle cells.  Cell Sig-
nal 2002, 14:899-911.
48. Beere HM: "The stress of dying": the role of heat shock pro-
teins in the regulation of apoptosis.  J Cell Sci 2004,
117:2641-2651.
49. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I,
Bernasconi L, Bernard A, Mermod JJ, Mazzei G, Maundrell K, Gambale
F ,  S a d o u l  R ,  M a r t i n o u  J C :  Inhibition of Bax channel-forming
activity by Bcl-2.  Science 1997, 277:370-372.
50. Donovan M, Cotter TG: Control of mitochondrial integrity by
Bcl-2 family members and caspase-independent cell death.
Biochim Biophys Acta 2004, 1644:133-147.
51. Boatright KM, Salvesen GS: Mechanisms of caspase activation.
Curr Opin Cell Biol 2003, 15:725-731.
52. Beere HM, Green DR: Stress management – heat shock pro-
tein-70 and the regulation of apoptosis.  Trends Cell Biol 2001,
11:6-10.
53. Tepperman BL, Jacobson ED: Circulatory factors in gastric
mucosal defense and repair.  In Physiology of the Gastroentestinal
Tract Third edition. Edited by: Johnson LR. New York: Raven Press;
1994:1331-1351. 
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-230X/6/22/pre
pub